|
1969 |
Frieder Kempe uses the principle of
the Faraday Cage to combat phantom pain. |
|
1972 |
Early variations of FARABLOC are
developed |
|
1979 |
The first generation of products are
found to give remarkable pain relief for amputees in Bavaria, Germany. |
|
1983 |
Incorporation of The FARABLOC
Development Corporation in Canada. |
|
1984 |
U.S. patent pending. |
|
1987 |
U.S. patent granted. |
|
1987 |
First major research study: Farabloc
in the Treatment of Phantom Pain, Rheumatic Pain and Other Painful
Symptoms ; Prof. G.L. Bach, M.D. Professor of Medicine/Rheumatology,
University of Munich, Germany, formerly Professor and Chairman,
Department of Clinical Immunology and Rheumatology - Chief, University
of Loyola - Medical Division at the Cook County Hospital, Chicago,
Illinois (USA) and the University of Loyola, Maywood, Illinois (USA). |
|
1988 |
Conclusion of tests and studies,
promoted by the Federal Government of Germany in Bonn and conducted by
the Bavarian Ministry (STMAS) in the Department of Supply and Services,
with no less than 68% success. |
|
1989 |
Permission granted by the Office of
Research Services of the University of British Columbia in Vancouver,
B.C., to conduct a double-blind crossover study. |
|
1989 |
U.S. Patent, EQUUSBLOC, also granted
for use in veterinary treatment. |
|
1991 |
Clinical trials conducted by Dr. J.D.
Twidale, M.A., Vet.M.B., M.R.C.V.S., Equine veterinarian - Changes in
Blood Count and Blood Chemistry while wearing Equusbloc (FARABLOC)
blanket.. Remarkable decrease of CPK enzyme. |
|
1992 |
Completion of the Double Blind
Cross-Over Designed University of British Columbia study, carried out
under a contract funded by the British Columbia Ministry of Health, The
Efficacy of FARABLOC™ in the Treatment of Phantom Limb Pain. |
|
1993 |
THE CANADIAN JOURNAL OF REHABILITATION
publishes the UBC study. |
|
1998 |
UBC conducts a further double-blind
study, The Efficacy of FARABLOC™ in Reduction of Delayed Onset Muscle
Soreness. |
|
1999 |
FDA Establishment Registration and
Device Listing for Farabloc-LC (Limb Cover) |
|
1999 |
Canadian Academy of Sport Medicine
Award - Robert Tait McKenzie Medallion |
|
2000 |
Health Canada: Medical Device
Establishment License |
|
2000 |
THE CLINICAL JOURNAL OF SPORT
MEDICINE, Philadelphia, PA, 10(1): 15-21, January, 2001 PMID: 10695845 [PubMed
- indexed for MEDLINE] The Efficacy of Farabloc™, an Electromagnetic
Shield In Delayed Onset Muscle Soreness; Jian Zhang M.Sc.. Douglas B.
Clement M.D., Jack E. Taunton M.D. |
|
2001 |
THE BRITISH COLUMBIA MEDICAL JOURNAL,
43: 10; Pages 573-577; December, 2001. Alleviation of pain with the use
of Farabloc, an electromagnetic shield: A review D.B. Clement, MD and
J.E. Taunton, MD |
|
2002 |
A Systematic Review: Evidence for the
Optimal Management of Acute and Chronic Phantom Pain by Julie Halbert,
M. Sc., Maria Crotty, Ph.D, Ian D. Cameron, Ph.D. Publication: THE
CLINICAL JOURNAL OF PAIN, Philadelphia, PA, 18(2): 84-92, March/April,
2002 PMID: 11882771 [PubMed - indexed for MEDLINE] |
|
2004 |
United Kingdom University of York,
U.K. Centre for Reviews and Dissemination Dare Abstract 20020730
Systematic Review of Clinical Journal of Pain, 2002; 18(2):84-92. |
|
2004 |
British Columbia Chiropractic
Association endorses Farabloc. |
|
2007 |
Major research breakthrough, Efficacy
of Farabloc as an analgesic in primary fibromyalgia; Bach GL, Clement
DB. Clin Rheumatol. 2007 Mar;26(3):405-10. Epub 2007 Jan 11. PMID:
17216399 [PubMed - indexed for MEDLINE]. Dr. Gerhard L. Bach of Germany,
who has an academic affiliation with the Department of Medicine /
Rheumatology at the University of Munich, conducted the research at
Clinic Auerbach, Bensheim. Dr. Douglas B. Clement, Professor Emeritus,
Division of Sports Medicine at the University of British Columbia,
compiled and analyzed the data. |
